The Foundation for Triglyceride Disorders

No one should navigate a triglyceride disorder alone. Formerly the FCS Foundation. 💙 FCS | MCS | sHTG | TiP

[The Foundation for Triglyceride Disorders @TGDisorders]

The FCS Foundation is now The Foundation for Triglyceride Disorders 💙 Same mission. Bigger reach — FCS, MCS, sHTG & TiP. https://t.co/8X265twWI3
@Amarincorp @ArrowheadPharma @ionispharma @advcardiohealth @ASPCardio @nationallipid @NatTgAlliance @NatPancFdn @TheAACE @HeartNurses

[National Triglyceride Alliance @NatTgAlliance]

Check out Module 4 to update your knowledge: https://t.co/vLNzwTkrZy

@SethJBaumMD @EliotBrinton @mmillermd1 @lipiddoc @ArchnaBajajMD @drmaggarwal @nationallipid @foundationofnla @ASPCardio @NatPancFdn @TGDisorders @TheAACE @HeartNurses @ionispharma @ArrowheadPharma @Amarincorp

#Triglycerides #Hypertriglyceridemia #FCS

[National Triglyceride Alliance @NatTgAlliance]

🧠 #TrigTriviaTuesday

Familial Chylomicronemia Syndrome (FCS) is caused by a deficiency in which enzyme?

Drop your answer below 👇 — reveal coming in the reply!

[National Triglyceride Alliance @NatTgAlliance]

Congratulations on 10 years of progress! We are excited for the next chapter @TGDisorders 💙

[The Foundation for Triglyceride Disorders @TGDisorders]

Thank you to our sponsors @Amarincorp @ArrowheadPharma @ionispharma for their unrestricted educational grants; our partners @advcardiohealth @ASPCardio @nationallipid @NatTgAlliance @NatPancFdn @TheAACE @HeartNurses; and our Medical Advisory Board. 💙

[The Foundation for Triglyceride Disorders @TGDisorders]

Today, celebrating 10 years of progress, the FCS Foundation officially becomes The Foundation for Triglyceride Disorders 🎉 Same mission. Bigger reach — FCS, MCS, sHTG, TiP & more. No one should navigate this alone.
https://t.co/5pwyILr3vC
#TriglyceridDisorders #FCSFoundation

[The Foundation for Triglyceride Disorders @TGDisorders]

🏃‍♂️ Join the Fred Saremi Memorial FCS Foundation Virtual 5K 💙

FCS is a rare genetic disorder (1 in 1M) which inhibits fat breakdown, often leading to life-threatening pancreatitis.

Support awareness, education & care. Sign up now to make a difference!

https://t.co/9qDMLhVQEH

[The Foundation for Triglyceride Disorders @TGDisorders]

🏃‍♂️ Join the Fred Saremi Memorial FCS Foundation Virtual 5K 💙

FCS is a rare genetic disorder (1 in 1M) that prevents the body from breaking down fats, often leading to life-threatening pancreatitis.

Support awareness, education & care.

https://t.co/9qDMLhVQEH

[The Foundation for Triglyceride Disorders @TGDisorders]

🏃‍♂️ Join the Fred Saremi Memorial FCS Foundation Virtual 5K 💙

FCS is a rare genetic disorder (1 in 1M) that prevents the body from breaking down fats, often leading to life-threatening pancreatitis.

Support awareness, education & care.

https://t.co/vLn3tkkB0S

[The Foundation for Triglyceride Disorders @TGDisorders]

Join Community Connections 💬
A supportive virtual space for people living with #FCS & caregivers, guided by rare disease psychologist Dr. Al Freedman.
🗓 May 13, 2026 | 6–7:30 PM ET
Connect, share, or just listen.
https://t.co/RK8nh0B928
Thanks to @ionispharma & @ArrowheadPharma

[The Foundation for Triglyceride Disorders @TGDisorders]

🏃‍♂️ Join the Fred Saremi Memorial FCS Foundation Virtual 5K 💙

FCS is a rare genetic disorder (1 in 1M) that prevents the body from breaking down fats, often leading to life-threatening pancreatitis.

Support awareness, education & care.

https://t.co/AUc40zTXYN

[The Foundation for Triglyceride Disorders @TGDisorders]

🏃‍♂️💙 Join the Fred Saremi Memorial FCS Foundation's Virtual 5K on June 11! You can run, walk, or jog from anywhere to support those living with Familial Chylomicronemia Syndrome. Every step makes a difference.

👉 Sign up: https://t.co/g4yr4DnfqO

#LivingWithFCS #RareDisease

[The Foundation for Triglyceride Disorders @TGDisorders]

🏃‍♂️💙 Join the Fred Saremi Memorial FCS Foundation Virtual 5K on June 11! Run, walk, or jog from anywhere to support those living with Familial Chylomicronemia Syndrome. Every step makes a difference.

👉 Sign up: https://t.co/g4yr4DnfqO

#LivingWithFCS #RareDisease #Virtual5K

[The Foundation for Triglyceride Disorders @TGDisorders]

Join Community Connections 💬
A supportive virtual space for people living with #FCS & caregivers, guided by rare disease psychologist Dr. Al Freedman.
🗓 May 13, 2026 | 6–7:30 PM ET
Connect, share, or just listen.
https://t.co/ZcENcN5mz0
Thanks to @ionispharma & @ArrowheadPharma

[National Triglyceride Alliance @NatTgAlliance]

March 28 is National Triglycerides Day — a reminder for clinicians to assess and manage triglyceride-related risk.

Elevated triglycerides may increase the risk of pancreatitis and cardiovascular disease.

Early screening, patient education, and evidence-based interventions are key to improving outcomes. Make triglyceride management part of your clinical workflow.

Featuring Seth J. Baum, MD, MASPC, FACC, FAHA, FNLA, Chairperson of the National Triglyceride Alliance and past president of the American Society for Preventive Cardiology.

@SethJBaumMD @EliotBrinton @mmillermd1 @lipiddoc @ArchnaBajajMD @drmaggarwal @nationallipid @ASPCardio @NatPancFdn @livingwithfcs @TheAACE @HeartNurses @ionispharma @ArrowheadPharma @Amarincorp

https://t.co/3ak62sxTpe

#NationalTriglyceridesDay #KnowYourRisk #HeartHealth #Triglycerides #FCSAwareness

[National Triglyceride Alliance @NatTgAlliance]

In just 12 months, the National Triglyceride Alliance has grown from an idea into a national movement advancing education, awareness, and patient support around triglyceride-related risk.

From launching clinician education to uniting leading medical organizations and advocacy partners, this first year shows what’s possible when a community comes together around an unmet need.

“Together we’re transforming awareness, education, and care. And we’re just getting started,” said Seth J. Baum, MD, MASPC, FACC, FAHA, FNLA, Chairperson of the National Triglyceride Alliance.

Thank you for being part of the journey. Here’s to year two.

@SethJBaumMD @EliotBrinton @mmillermd1 @lipiddoc @ArchnaBajajMD @drmaggarwal @nationallipid @ASPCardio @NatPancFdn @livingwithfcs @TheAACE @HeartNurses @ionispharma @ArrowheadPharma @Amarincorp

https://t.co/3ak62sxTpe

#Triglycerides #CardiometabolicHealth #MedicalEducation #Cardiology #PreventiveMedicine #HealthcareInnovation #PatientAdvocacy

[Foundation of the NLA @foundationofnla]

If you're living with extremely high triglycerides or FCS, the fear of a pancreatitis episode can feel ever-present. This 1 min exercise is designed to help calm your nervous system and restore a sense of control.

This project was supported by @arrowheadpharma and @ionis_pharma.

[National Triglyceride Alliance @NatTgAlliance]

One year of impact—and we’re just getting started.

The National Triglyceride Alliance was founded on a simple idea: triglycerides deserve more attention as a critical driver of cardiovascular and metabolic health.

Since then?

✔️ A growing national coalition
✔️ New education and clinical resources
✔️ Expanded awareness for patients and providers

As we approach #NationalTriglyceridesDay (March 28), we’re reminded that progress starts with awareness—and continues with action.

Let’s keep pushing forward.

Read the press release: https://t.co/1Cp1pfucyD

@SethJBaumMD @EliotBrinton @mmillermd1 @lipiddoc @ArchnaBajajMD @drmaggarwal @nationallipid @ASPCardio @NatPancFdn @livingwithfcs @TheAACE @HeartNurses @ionispharma @ArrowheadPharma @Amarincorp

#Triglycerides #Cardiology #MedEd #HealthcareInnovation

[The Foundation for Triglyceride Disorders @TGDisorders]

Multisociety dyslipidemia guidelines highlight the importance of recognizing & managing severe hypertriglyceridemia—critical for people living with FCS.
Earlier recognition & clearer care pathways reduce pancreatitis risk & improve access to treatment.
https://t.co/NyC5xG96iC

[National Triglyceride Alliance @NatTgAlliance]

📢 New multisociety dyslipidemia guidelines are here.
The 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia brings together leading organizations to advance evidence-based care for lipid management and cardiovascular risk reduction.
The updated 2026 ACC/AHA Dyslipidemia Guideline places a major new emphasis on triglycerides (TG) as both an ASCVD risk enhancer and a driver of pancreatitis risk. Here are the key takeaways:
➡️ Triglycerides matter more than ever.
Elevated TG are now recognized as contributors to atherogenic remnant particles—raising ASCVD risk—starting at fasting ≥150 mg/dL or nonfasting ≥175 mg/dL. Persistent elevation is officially listed as a risk enhancer in overall cardiovascular risk assessment.
➡️ Lifestyle is the foundation of TG management.
The guideline strongly reinforces that the first-line intervention for TG ≥150 mg/dL is lifestyle: lowering added sugars and refined carbs, reducing saturated fat, minimizing alcohol, adopting plant-forward dietary patterns, increasing physical activity, and aiming for 5–10% weight loss.
➡️ TG ≥500 mg/dL = elevated pancreatitis risk.
Levels at or above 500 mg/dL significantly increase the risk of acute pancreatitis, with ≥1000 mg/dL demanding urgent dietary intervention and elimination of alcohol and added sugars.
➡️ Statins remain first-line for ASCVD, even with high TG.
Statins reduce TG modestly (10–30%) and remain foundational for ASCVD prevention in patients with elevated triglycerides.
➡️ Additional TG‑lowering therapy for higher levels.
For TG 500–999 mg/dL, adding fibrates or prescription omega‑3 fatty acids is reasonable to reduce pancreatitis risk. For ≥1000 mg/dL, these therapies become even more critical, along with strict dietary fat restriction.
➡️ A major update: Olezarsen for FCS.
For patients with familial chylomicronemia syndrome (FCS) and TG ≥1000 mg/dL, the guideline recommends Olezarsen, an apoC‑III inhibitor shown to significantly lower TG and reduce pancreatitis episodes.
➡️ Referral to an RDN is now a Class 1 recommendation.
For TG ≥1000 mg/dL—and even TG 150–999 mg/dL with CKM syndrome—working with a Registered Dietitian Nutritionist is strongly recommended to tailor nutrition therapy.

https://t.co/js5b5QCIYT

@SethJBaumMD @EliotBrinton @mmillermd1 @lipiddoc @ArchnaBajajMD @drmaggarwal @nationallipid @ASPCardio @NatPancFdn @livingwithfcs @TheAACE @HeartNurses @ionispharma @ArrowheadPharma @Amarincorp